"large cell cancer" trang 2 - tải miễn phí từ tailieunhanh
A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: A large population-based cohort study and external validation

A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: A large population-based cohort study and external validation
13    5    1
Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
9    100    0
MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index
12    103    0
Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma

Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma
10    119    0
Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
8    72    0
Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report

Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report
8    98    0
Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
10    97    0
An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
8    91    1
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol
8    51    1
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
7    61    1
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
7    49    1
Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience
8    30    1
Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
12    68    1
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement
7    33    1
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma
7    64    1
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation
10    30    1
Clinical characteristics and prognostic factors of bone lymphomas: Focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

Clinical characteristics and prognostic factors of bone lymphomas: Focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
9    55    1
Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas

Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas
10    33    1
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis
11    47    1
Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study

Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study
6    40    1